SUREFIRE RESOURCES NL — Director's Dealing 2007

Dec 26, 2007

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: GENESIS BIOMEDICAL LIMITED

ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR. DONALD VALENTINO
Date of last notice	26th MARCH 2007

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Don Valentino is a Director of :JAYVEE INVESTMENTS PTY LTD
Date of change	21 DECEMBER 2007
No. of securities held prior to change
DON VALENTINO	1,700,000 Unlisted Options exercisable at 4centseachonorbefore31December 20071,700,000 Unlisted Options exercisable at 4cents each on or before 30 June20091,700,000 Unlisted Options exercisable at 4centseachonorbefore31December 2010
JAYVEE INVESTMENTS PTY LTD	4,798,267 Fully Paid Ordinary Shares4,498,267 Listed Options exercisable at 3cents on or before 30 November2010

Class	a)Ordinary Shares
	b)Listed Options exercisable at 3 cents each
	on or before 30 November 2010
Number acquired	a)2,600,000 Fully Paid Ordinary Shares
	b)1,300,000 Listed Options
Number disposed	Nil
Value/Consideration	a)$54,600.00
Note: If consideration is non-cash, provide details and estimated
valuation	b)$ NIL
No. of securities held after change
DON VALENTINO	1,700,000 Unlisted Options exercisable at 4
	centseachonorbefore31
	December 2007
	1,700,000 Unlisted Options exercisable at 4
	cents each on or before 30 June
	2009
	1,700,000 Unlisted Options exercisable at 4
	centseachonorbefore31
	December 2010
JAYVEE INVESTMENTS PTY LTD	7,398,267 Fully Paid Ordinary Shares
	5,798,267 Listed Options exercisable at 3
	cents each on or before 30 November 2010
Nature of change	Participation in issue of securities approved
Example: on-market trade, off-market trade, exercise of options, issue of	byshareholdersatAGMheldon19
securities under dividend reinvestment plan, participation in buy-back	November 2007.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relationto which the interest has changed
Interest acquired

+ See chapter 19 for defined terms.

Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: GENESIS BIOMEDICAL LIMITED

ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR. ROGER SMITH
Date of last notice	18th JUNE 2007

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Roger Smith is a Director of the following:ROGON NOMINEES PTY LTDEACH NOMINEES PTY LTDHALITH PTY LTDCHIBAI PTY LTDRoger Smith has a beneficial interest insecurities held by:BRYSON MOTORSPORT PTY LTD
Date of change	21 DECEMBER 2007
No. of securities held prior to changeROGER SMITHROGON NOMINEES PTY LTDEACH NOMINEES PTY LTDHALITH PTY LTDCHIBAI PTY LTDBRYSON MOTORSPORT PTY LTD	3,000,000 Unlisted Options exercisable at 10centseachonorbefore31December 20112,000,000 Fully Paid Ordinary Shares1,000,000 Fully Paid Ordinary Shares740,523 Fully Paid Ordinary Shares400,000 Fully Paid Ordinary Shares1,000,000 Fully Paid Ordinary Shares
Class	a) Ordinary Sharesb) Listed Options exercisable at 3 cents eachon or before 30 November 2010

Number acquired	a)750,000 Fully Paid Ordinary Shares
	b)375,000 Listed Options
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	a)$15,750.00b)$ NIL
No. of securities held after change
ROGER SMITH	3,000,000 Unlisted Options exercisable at 10cents each on or before 31 December 2011
ROGON NOMINEES PTY LTD	3,000,000 Fully Paid Ordinary Shares1,000,000Options$0.03,30November2010
EACH NOMINEES PTY LTD	1,000,000 Fully Paid Ordinary Shares
HALITH PTY LTD	1,490,523 Fully Paid Ordinary Shares375,000 Options $0.03, 30 November 2010
CHIBAI PTY LTD	400,000 Fully Paid Ordinary Shares
BRYSON MOTORSPORT PTY LTD	1,000,000 Fully Paid Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Participation in issue of securities approvedbyshareholdersatAGMheldon19November 2007.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change

+ See chapter 19 for defined terms.

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: GENESIS BIOMEDICAL LIMITED

ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR. RODGER JOHNSTON
Date of last notice	8th DECEMBER 2005

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Roger Johnston has a beneficial interest insecurities held by:ROX CAPITAL LIMITED
Date of change	21 DECEMBER 2007
No. of securities held prior to changeRODGER JOHNSTON	3,000,000 Unlisted Options exercisable at 10centseachonorbefore31December 2011
Class	a) Ordinary Sharesb) Listed Options exercisable at 3 cents eachon or before 30 November 2010
Number acquired	a)1,000,000 Fully Paid Ordinary Sharesb) 500,000 Options
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	a)$21,000.00b)$ NIL

No. of securities held after changeROGER JOHNSTON	3,000,000 Unlisted Options exercisable at 10cents each on or before 31 December 2011
ROX CAPITAL LIMITED	1,000,000 Fully Paid Ordinary Shares500,000 Listed Options exercisable at 3centseachonorbefore30/11/2010
Nature of change	Participation in issue of securities approved
Example: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	byshareholdersatAGMheldon19November 2007.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change

+ See chapter 19 for defined terms.